Showing results (651-660 of 870) with videos related to

Sort By:
Pageof 87
Movement Disorders : Official Journal of the Movement Disorder Society|October 21, 2025
Feasibility of Simon Two-Stage Futility Trials in People with Early, Symptomatically Treated Parkinson's DiseaseMarcus W Koch, Lorraine V Kalia, Justyna Sarna, et al.
Open Forum Infectious Diseases|December 12, 2017
Enteric Microbiome Markers as Early Predictors of Clinical Outcome in Allogeneic Hematopoietic Stem Cell Transplant: Results of a Prospective Study in Adult PatientsNicasio Mancini, Raffaella Greco, Renée Pasciuta, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 20, 2024
Statistical considerations when estimating time-saving treatment effects in Alzheimer's disease clinical trialsGuoqiao Wang, Gary Cutter, Neil P Oxtoby, et al.
Plos One|March 7, 2014
Radiologically isolated syndrome: 5-year risk for an initial clinical eventDarin T Okuda, Aksel Siva, Orhun Kantarci, et al.
JAMA|January 30, 2004
Effect of breast augmentation on the accuracy of mammography and cancer characteristicsDiana L Miglioretti, Carolyn M Rutter, Berta M Geller, et al.
The Lancet. Neurology|November 23, 2020
Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trialBruce A C Cree, Gary Cutter, Jerry S Wolinsky, et al.
Neurobiology of Disease|July 3, 2025
[18F]FDG PET metabolic correlates of cerebrospinal fluid TAR DNA-binding protein 43 in prodromal Alzheimer's diseaseVirginia Pelagotti, Domenico Plantone, Francesca D'Amico, et al.
The New England Journal of Medicine|September 30, 2016
Adjunctive Azithromycin Prophylaxis for Cesarean DeliveryAlan T N Tita, Jeff M Szychowski, Kim Boggess, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 7, 2019
Periventricular magnetisation transfer ratio abnormalities in multiple sclerosis improve after alemtuzumabJ William L Brown, Ferran Prados Carrasco, Arman Eshaghi, et al.
Bone Marrow Transplantation|September 30, 2025
BEAM/ATG or cyclophosphamide/ATG as conditioning regimen in autologous haemopoietic stem cell transplantation for multiple sclerosis: a retrospective analysis of the EBMT autoimmune diseases working partyRaffaella Greco, Riccardo Saccardi, Marta Ponzano, et al.
Pageof 87